Ahlcon Parenterals (India) has initiated programme for expansion of capacities, at its existing Bhiwadi plant in Rajasthan, the estimated cost of which is approximately Rs 190 crore, to be met through debts / internal accruals. The company expects to commence commercial production in quarter ended December 2014.
Ahlcon Parenterals (India) manufactures pharmaceutical intravenous (I.V.) fluids, medical disposables, and opthalmics/ear drops. It offers I.V. fluids, antimicrobial I.V. fluids, plasma volume expanders in BFS bottles, and nasal drops.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.95 |
| Dr. Reddys Lab | 1315.85 |
| Cipla | 1294.75 |
| Zydus Lifesciences | 927.15 |
| Lupin | 2296.10 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: